Literature DB >> 4147429

The action of ICI-66082 on the heart.

J D Harry, M F Knapp, R J Linden.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4147429      PMCID: PMC1776231     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Effects of -adrenoreceptor blocking drugs on isolated skeletal and cardiac muscle.

Authors:  J D Harry; R J Linden; H M Snow
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

2.  The action of propranolol on the dog heart.

Authors:  J D Harry; R J Linden; H M Snow
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

3.  Inotropic changes in the left ventricle: the effect of changes in heart rate, aortic pressure and end-diastolic pressure.

Authors:  C M Furnival; R J Linden; H M Snow
Journal:  J Physiol       Date:  1970-12       Impact factor: 5.182

  3 in total
  9 in total

1.  A simple spectrophotofluorometric method for the measurement of I.C.I. 66082 in plasma and urine.

Authors:  C M Kaye
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

2.  An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.

Authors:  G E Marlin; C R Kumana; C M Kaye; D M Smith; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

3.  Effects of atenolol on regional myocardial blood flow and ST segment elevation in the canine myocardium.

Authors:  A Berdaux; J R Bossier; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

4.  Proceedings: Antagonism by ICI 66082 of the effects of electrical stimulation on the right ansa subclavia of the dog.

Authors:  J D Harry; M F Knapp; R J Linden
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

Review 5.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

6.  Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.

Authors:  F J Conway; J D Fitzgerald; J McAinsh; D J Rowlands; W T Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

7.  The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.

Authors:  J D Harry; M F Knapp; R J Linden
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

8.  Pharmacokinetics, pharmacology of atenolol and effect of renal disease.

Authors:  S H Wan; R T Koda; R F Maronde
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

9.  Failure of isoprenaline and beta-receptor blocking drugs to modify depressor response and bradycardia induced by electrical stimulation of the anterior hypothalamus of cats.

Authors:  T Iijima; A Philippu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.